Market Place
Sourcing Support
Disc Medicine Announces Completion of Merger with Gemini Therapeutics
29 Dec 2022 //
BIOSPACE
Gemini’s fall gives Disc a way around biotech’s IPO slump
11 Aug 2022 //
BIOPHARMADIVE
Gemini Therapeutics Reports 2021 Financial Results
10 Mar 2022 //
BUSINESSWIRE
Gemini Therapeutics Provides GEM103 Program Update
10 Jan 2022 //
BUSINESSWIRE
Gemini Therapeutics Reports Q3 2021 Financial Results & Provides Business Update
15 Nov 2021 //
BUSINESSWIRE
Gemini Therapeutics Announces Presentation at 2nd Annual Dry AMD Therapeutic
19 Oct 2021 //
BUSINESSWIRE
Gemini axes CSO and 20% of staff to focus on late-phase plans
06 Oct 2021 //
ENDPTS
Gemini Therapeutics Announces Presentation of Preclinical Data
10 Sep 2021 //
BUSINESSWIRE
Gemini to Participate in the H.C. Wainwright 23rd Global Investment Conference
07 Sep 2021 //
BUSINESSWIRE
Gemini to Present Data from Its Phase 2a Study of GEM103 at the Summit
30 Aug 2021 //
BUSINESSWIRE
Gemini Therapeutics Reports Second Quarter 2021 Financial Results and Updates
12 Aug 2021 //
BUSINESSWIRE
Gemini Therapeutics to attend the H.C. Wainwright Ophthalmology Conference
10 Aug 2021 //
BUSINESSWIRE
Gemini Therapeutics Completes Enrollment in Phase 2a Study of GEM103
13 May 2021 //
BLOOMBERG
Gemini Therapeutics Completes Enrollment in Phase 2a Study of GEM103
13 May 2021 //
BUSINESSWIRE
Gemini Tx Announces Appointment of Georges Gemayel, Chair of Board of Directors
03 May 2021 //
BUSINESSWIRE
Gemini Therapeutics Completes Enrollment in Phase 2a Trial of GEM103
10 Feb 2021 //
BUSINESSWIRE
Gemini Therapeutics commences Wet AMD treatment trial
02 Feb 2021 //
CLINICALTRIALSARENA
Gemini Therapeutics Announces Initiation of GEM103 Phase 2a Study as an Add-On
01 Feb 2021 //
BUSINESSWIRE
Gemini Announces FDA Fast Track Designation Granted for GEM103
07 Jan 2021 //
BUSINESSWIRE
Gemini Announces FDA Fast Track Designation Granted for GEM103
07 Jan 2021 //
BUSINESSWIRE
Gemini Announces GEM103 Meets All Endpoints in Phase 1 Clinical Study
13 Nov 2020 //
PRESS RELEASE
Gemini Therapeutics Announces GEM103 Meets All Endpoints in Ph1 Study
13 Nov 2020 //
BUSINESSWIRE
Gemini Therapeutics and FS Development Corp. Announce Merger Agreement
15 Oct 2020 //
BUSINESSWIRE
Gemini Therapeutics and FS Development Corp. Announce Merger Agreement
15 Oct 2020 //
BIOSPACE
Gemini & Singapore Eye Research Institute Enter Into Research Collaboration
26 Feb 2020 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.